ABRT — Albert Labs International Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Albert Labs International, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0 | — | — | — | 0.079 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0 | 0 | — | — | 0.012 |
Prepaid Expenses | |||||
Total Current Assets | 0.002 | 0 | — | — | 0.091 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | — | — | 0.072 |
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 0.002 | 0 | 0 | 0 | 0.164 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.23 | 1.53 | 1.81 | 2.09 | 0.529 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.23 | 1.53 | 1.81 | 2.09 | 0.529 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -1.23 | -1.53 | -1.81 | -2.09 | -0.365 |
Total Liabilities & Shareholders' Equity | 0.002 | 0 | 0 | 0 | 0.164 |
Total Common Shares Outstanding |